Inmune Bio Stock Price History
| INMB Stock | USD 2.34 0.04 1.68% |
Below is the normalized historical share price chart for INmune Bio extending back to February 04, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of INmune Bio stands at 2.34, as last reported on the 22nd of July, with the highest price reaching 2.34 and the lowest price hitting 2.34 during the day.
If you're considering investing in INmune Stock, it is important to understand the factors that can impact its price. INmune Bio holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had a -0.15 % return per unit of risk over the last 3 months. INmune Bio exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out INmune Bio's Risk Adjusted Performance of (0.11), market risk adjusted performance of (1.11), and Standard Deviation of 9.17 to validate the risk estimate we provide. At present, INmune Bio's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 41.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 13.9 M. . At present, INmune Bio's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 3.05, whereas Price To Sales Ratio is forecasted to decline to 5,149. INmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of February 2019 | 200 Day MA 6.5007 | 50 Day MA 5.9108 | Beta 1.567 |
Sharpe Ratio = -0.1489
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INMB |
Estimated Market Risk
| 9.44 actual daily | 84 84% of assets are less volatile |
Expected Return
| -1.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average INmune Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INmune Bio by adding INmune Bio to a well-diversified portfolio.
Price Book 2.2216 | Enterprise Value Ebitda (5.31) | Price Sales 1.3 K | Shares Float 15.2 M | Wall Street Target Price 14.72 |
INmune Bio Stock Price History Chart
There are several ways to analyze INmune Stock price data. The simplest method is using a basic INmune candlestick price chart, which shows INmune Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 11, 2025 | 8.09 |
| Lowest Price | July 15, 2025 | 2.07 |
INmune Bio July 22, 2025 Stock Price Synopsis
Various analyses of INmune Bio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell INmune Stock. It can be used to describe the percentage change in the price of INmune Bio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of INmune Stock.| INmune Bio Price Rate Of Daily Change | 0.98 | |
| INmune Bio Price Action Indicator | (0.02) |
INmune Bio July 22, 2025 Stock Price Analysis
INmune Stock Price History Data
The price series of INmune Bio for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 6.17 with a coefficient of variation of 35.46. Under current investment horizon, the daily prices are spread out with arithmetic mean of 6.26. The median price for the last 90 days is 7.35.| Open | High | Low | Close | Volume | ||
07/22/2025 | 2.38 | 2.34 | 2.34 | 2.34 | ||
07/21/2025 | 2.41 | 2.46 | 2.27 | 2.38 | 1,573,603 | |
07/18/2025 | 2.26 | 2.48 | 2.24 | 2.42 | 1,976,482 | |
07/17/2025 | 2.27 | 2.28 | 2.17 | 2.24 | 1,124,874 | |
07/16/2025 | 2.06 | 2.36 | 2.05 | 2.34 | 2,919,698 | |
07/15/2025 | 2.13 | 2.18 | 2.04 | 2.07 | 1,407,804 | |
07/14/2025 | 2.31 | 2.33 | 2.12 | 2.12 | 1,554,739 | |
07/11/2025 | 2.22 | 2.35 | 2.18 | 2.31 | 1,406,655 | |
07/10/2025 | 2.33 | 2.39 | 2.21 | 2.23 | 1,898,051 | |
07/09/2025 | 2.30 | 2.49 | 2.23 | 2.36 | 1,954,368 | |
07/08/2025 | 2.28 | 2.40 | 2.22 | 2.30 | 1,765,557 | |
07/07/2025 | 2.50 | 2.50 | 2.24 | 2.30 | 3,306,818 | |
07/03/2025 | 2.31 | 2.77 | 2.30 | 2.53 | 4,699,962 | |
| 07/02/2025 | 2.07 | 2.43 | 2.04 | 2.36 | 5,911,976 | |
| 07/01/2025 | 2.09 | 2.22 | 1.89 | 2.09 | 8,769,289 | |
| 06/30/2025 | 2.04 | 2.34 | 2.00 | 2.31 | 32,730,789 | |
| 06/27/2025 | 9.30 | 11.64 | 5.01 | 5.33 | 59,667,457 | |
06/26/2025 | 7.40 | 7.64 | 6.11 | 6.28 | 4,367,750 | |
06/25/2025 | 6.61 | 7.40 | 6.61 | 7.37 | 921,051 | |
06/24/2025 | 6.47 | 6.97 | 6.36 | 6.61 | 974,573 | |
06/23/2025 | 5.95 | 6.58 | 5.60 | 6.22 | 2,098,709 | |
06/20/2025 | 7.30 | 7.49 | 6.16 | 6.38 | 1,492,039 | |
06/18/2025 | 7.04 | 7.47 | 6.81 | 7.24 | 1,004,862 | |
| 06/17/2025 | 8.02 | 8.04 | 6.68 | 6.87 | 1,746,939 | |
06/16/2025 | 7.78 | 8.05 | 7.60 | 8.02 | 672,038 | |
06/13/2025 | 7.73 | 8.01 | 7.65 | 7.70 | 595,038 | |
06/12/2025 | 7.99 | 8.21 | 7.47 | 7.92 | 649,682 | |
06/11/2025 | 7.94 | 8.29 | 7.81 | 8.09 | 784,943 | |
06/10/2025 | 7.79 | 8.28 | 7.78 | 7.88 | 855,359 | |
| 06/09/2025 | 7.74 | 8.09 | 7.57 | 7.65 | 887,284 | |
06/06/2025 | 7.48 | 7.77 | 7.37 | 7.62 | 427,646 | |
06/05/2025 | 7.70 | 7.70 | 7.27 | 7.35 | 495,653 | |
06/04/2025 | 7.65 | 8.05 | 7.40 | 7.63 | 751,007 | |
06/03/2025 | 7.28 | 7.38 | 7.01 | 7.27 | 483,285 | |
06/02/2025 | 7.47 | 7.59 | 7.15 | 7.19 | 388,677 | |
05/30/2025 | 7.35 | 7.59 | 7.15 | 7.38 | 368,959 | |
05/29/2025 | 7.40 | 7.65 | 7.33 | 7.36 | 287,760 | |
05/28/2025 | 7.75 | 7.81 | 7.25 | 7.36 | 338,059 | |
05/27/2025 | 7.50 | 7.81 | 7.47 | 7.65 | 301,359 | |
05/23/2025 | 7.40 | 7.70 | 7.29 | 7.30 | 304,816 | |
05/22/2025 | 7.41 | 7.75 | 7.31 | 7.50 | 341,651 | |
05/21/2025 | 7.67 | 7.92 | 7.43 | 7.46 | 235,586 | |
05/20/2025 | 7.80 | 7.93 | 7.65 | 7.68 | 237,400 | |
05/19/2025 | 7.63 | 8.06 | 7.63 | 7.77 | 342,676 | |
05/16/2025 | 7.34 | 7.94 | 7.29 | 7.86 | 296,965 | |
05/15/2025 | 7.43 | 7.53 | 7.19 | 7.29 | 194,476 | |
05/14/2025 | 8.20 | 8.20 | 7.34 | 7.43 | 294,184 | |
05/13/2025 | 7.73 | 8.09 | 7.52 | 8.06 | 327,535 | |
05/12/2025 | 7.13 | 7.64 | 7.10 | 7.64 | 297,267 | |
05/09/2025 | 7.77 | 7.77 | 6.85 | 6.97 | 238,220 | |
05/08/2025 | 7.35 | 7.53 | 7.02 | 7.09 | 213,476 | |
05/07/2025 | 7.12 | 7.20 | 6.98 | 7.14 | 195,621 | |
05/06/2025 | 7.50 | 7.58 | 6.99 | 7.13 | 306,034 | |
05/05/2025 | 7.76 | 7.76 | 7.40 | 7.55 | 132,157 | |
05/02/2025 | 7.60 | 8.00 | 7.56 | 7.76 | 224,791 | |
05/01/2025 | 7.93 | 7.93 | 7.53 | 7.59 | 175,931 | |
04/30/2025 | 7.76 | 8.00 | 7.65 | 7.86 | 167,958 | |
04/29/2025 | 7.85 | 8.10 | 7.70 | 7.85 | 186,050 | |
04/28/2025 | 7.77 | 7.96 | 7.60 | 7.90 | 147,193 | |
04/25/2025 | 7.96 | 8.04 | 7.70 | 7.82 | 126,317 | |
04/24/2025 | 8.23 | 8.25 | 7.78 | 8.04 | 216,495 |
About INmune Bio Stock history
INmune Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for INmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in INmune Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing INmune Bio stock prices may prove useful in developing a viable investing in INmune Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 19.9 M | 13.9 M | |
| Net Loss | -24.6 M | -23.3 M |
INmune Bio Quarterly Net Working Capital |
|
INmune Bio Stock Technical Analysis
INmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
INmune Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for INmune Bio's price direction in advance. Along with the technical and fundamental analysis of INmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of INmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.29) | |||
| Total Risk Alpha | (2.49) | |||
| Treynor Ratio | (1.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |